Its Panel on Dietetic Products, Nutrition and Allergies (NDA) denied the article 13.5 claim made by Dutch-based The Natural Push-Up Company containing two randomised controlled trials for lack of causality between consuming the supplements and female breast enhancement. The proposed claim related to women aged from 18 to menopause. The NDA said the dossier, which contained two randomised controlled trials, failed to “establish that firmer and fuller breasts per se is a measure of breast function or beneficial to human health.” It also contained one analytical study and a rat study, both of which were “not considered pertinent to the claim.” “The Panel considers that the significant weaknesses of these two intervention studies limit their value as a source of data to substantiate the claimed effect,” NDA said. The opinion can be found here.
